Teleflex Announces First Patient Enrollment in CTO-PCI IDE Study

NEXT STORY
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
PREV STORY
Toronto centre solving cell manufacturing challenges to benefit patients and global industry
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors  

Tomasello is a Renowned Industry Expert Responsible for the Commercialization of Revolutionary, Multi-Billion Dollar ...

author_avatar
NASDAQ Market News

Coloplast delivers 8% organic revenue growth and upgrades full-year growth expectations

Coloplast delivered 8% organic revenue growth and a 31% EBIT margin at constant exchange ...

author_avatar
NASDAQ Market News

CytomX Announces First Quarter 2016 Financial Results

SOUTH SAN FRANCISCO, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News